Association between smoking status and the parameters of vascular structure and function in adults : results from the EVIDENT study by Recio Rodríguez, Jose I. et al.
Recio-Rodriguez et al. BMC Cardiovascular Disorders 2013, 13:109
http://www.biomedcentral.com/1471-2261/13/109RESEARCH ARTICLE Open AccessAssociation between smoking status and the
parameters of vascular structure and function in
adults: results from the EVIDENT study
Jose I Recio-Rodriguez1*, Manuel A Gomez-Marcos1, Maria C Patino Alonso2, Carlos Martin-Cantera3,
Elisa Ibañez-Jalon4, Amor Melguizo-Bejar5, Luis Garcia-Ortiz1 and on behalf of the EVIDENT GroupAbstract
Background: The present study analyses the relation between smoking status and the parameters used to assess
vascular structure and function.
Methods: This cross-sectional, multi-centre study involved a random sample of 1553 participants from the EVIDENT
study. Measurements: The smoking status, peripheral augmentation index and ankle-brachial index were measured
in all participants. In a small subset of the main population (265 participants), the carotid intima-media thickness
and pulse wave velocity were also measured.
Results: After controlling for the effect of age, sex and other risk factors, present smokers have higher values of
carotid intima-media thickness (p = 0.011). Along the same lines, current smokers have higher values of pulse wave
velocity and lower mean values of ankle-brachial index but without statistical significance in both cases.
Conclusions: Among the parameters of vascular structure and function analysed, only the IMT shows association
with the smoking status, after adjusting for confounders.
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A consistent relationship has been demonstrated between
cigarette smoke exposure and the progression of carotid
atherosclerosis [1], with a strong positive association with
coronary artery calcium burden [2]. Smoking has been
associated with increased arterial stiffness and central
hemodynamic indices [3-6]. There is evidence that the
ankle-brachial index inversely and linearly correlates with
cigarette smoking [7,8]. Nevertheless, when evaluating
vascular structure and function, every test has different
accessibility and costs [9]. Several authors have proposed
that the patient’s age, sex, blood pressure and heart rate,
and the presence of obesity, diabetes and vascular drugs,
are the main determinants of the parameters that assess
arterial stiffness and vascular function [10-13]. The aim of
this study was to assess the relationship between smoking* Correspondence: donrecio@gmail.com
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distribution, and reproduction in any mediumstatus and vascular structure and function in a random
sample of the adult population from the EVIDENT study.Methods
Study design and population
The EVIDENT study is a cross-sectional and multi-centre
study of six patient groups distributed throughout Spain.
Participants, aged 20–80 years, were selected by stratified
random sampling. The following exclusion criteria were
applied: known coronary or cerebrovascular atherosclerotic
disease, heart failure, moderate or severe chronic obstruct-
ive pulmonary disease, walking-limiting musculoskel-
etal disease, advanced respiratory, renal or hepatic disease,
severe mental disease, treated oncological disease diag-
nosed in the past 5 years and terminal illness. The study
was approved by an independent ethics committee from
Salamanca University Hospital (Spain), and all participants
provided written informed consent according to the gen-
eral recommendations of the Declaration of Helsinki. The
recruitment and data collection were conducted betweend Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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in the study. The sample size calculation indicated that
this number was sufficient to detect a difference of 5 units
in the peripheral augmentation index between 3 smoking
statuses (i.e., smoker, former smoker and non-smoker) in
a two-sided test, assuming a common standard deviation
(SD) of 21 units with a significance level of 95% and a
power of 90%. The IMT and PWV were measured in only
265 participants, but this number was sufficient to detect
a 0.05 mm difference in the IMT between the 3 groups,
assuming a SD of 0.1, a significance level of 95% and a
power of 80%. The findings presented in this manuscript
are a subanalysis of the EVIDENT study, the main results
of which were recently published [14].
Variables and measurement instruments
Smoking history was assessed by asking questions about
the participant’s smoking status. For the analyses, the
participants were classified as non-smokers, former
(>1 year without smoking) or present smokers. Carotid
ultrasonography to assess intima-media thickness of the
common carotid artery (C-IMT) was performed with the
Sonosite Micromax ultrasound device (Sonosite Inc.,
Bothell, Washington, USA) paired with a 5–10 MHz multi-
frequency high-resolution linear transducer. Sonocal soft-
ware was used to perform automatic IMT measurements.
Six measurements were performed on each carotid artery
using average values (average IMT) and maximum values
(maximum IMT) automatically calculated by the software.
The measurements were taken following the recommenda-
tions of the Manheim Carotid Intima-Media Thickness
Consensus [15]. Carotid-femoral pulse wave velocity (PWV)
was estimated using the SphygmoCor System (AtCor
Medical Pty Ltd., Head Office, West Ryde, Australia),
according to the expert consensus document on arterial
stiffness by Van Bortel et al. [16]. The central blood
pressure and radial or peripheral augmentation index
(PAIx) were measured with the Pulse Wave Application
Software (A Pulse) (HealthSTATS International, Singapore)
using tonometry to capture the radial pulse and to estimate
the central blood pressure using a patented equation.
The PAIx was calculated as follows: (second peak systolic
blood pressure [SBP2] - diastolic blood pressure [DBP])/
(first peak SBP - DBP) × 100 (%). The PAIx was standar-
dised to a heart rate of 75 bpm. The ankle-brachial index
(ABI) was measured using a portable WatchBP Office ABI
(Microlife AG Swiss Corporation). The ABI was calculated
automatically dividing the higher of the two ankle systolic
pressures by the highest measurement of the two systolic
pressures in the arm [17]. All measurements (IMT, PWV,
PAIx75 and ABI) were performed in the morning. Smoking
was not allowed within the 3 h prior to the measurements.
Further details on the EVIDENT study design have been
published elsewhere [18].Statistical analysis
Statistical normality was checked using the Kolmogorov–
Smirnov test. Normally distributed continuous variables
were expressed as the mean ± standard deviation, while
non-normally distributed variables were presented as
median and 75–25th percentile. Frequency distribution was
used for the categorical variables. The difference in means
in continuous variables between the smoking categories
was analysed using a one-way analysis of variance for inde-
pendent samples and the post-hoc Scheffé contrast, with
alpha <0.05 and the Kruskal–Wallis test when the variables
were not normal. Chi-squared tests were used to compare
the differences in categorical variables.
Age, sex, blood pressure, heart rate, and the presence
of obesity, diabetes and vascular drugs have shown to
affect the PWV, IMT or augmentation index values.
Therefore, it is necessary to control the effect of these
variables in the relationship between smoking status and
the parameters of vascular structure and function. To ana-
lyse the relationship between the vascular structure and
function (IMT, PAIx75, PWV or ABI) and smoking status
(non-smoker = 0, present smoker = 1, former smoker =2),
a general linear model (GLM) analysis was performed,
including age, sex, systolic blood pressure, heart rate, body
mass index, HDL cholesterol, diabetes and the presence of
antihypertensive, antidiabetic and lipid-lowering drugs as
the adjustment variables. The non-normal variables were
modelled as continuous variables with log transformation
to achieve normality in the multivariate analysis. Data
were analysed using the SPSS version 18.0 statistical pack-
age (SPSS Inc., Chicago, Illinois, USA), and p < 0.05 was
considered to be statistically significant.
Results
Table 1 shows the clinic characteristics of each group
according to its smoking status. Current smokers are
younger and have the lowest prevalence of hypertension,
obesity and dyslipidemia. PWV, IMT and ABI are lower in
present smokers, while PAIx75 are higher in these individ-
uals. An analysis of the 265 individuals for whom the IMT
and PWV were performed is shown in Additional file 1:
Table S1. The results showed that the demographic and
biological characteristics, according to smoking status,
were similar to the overall analysed sample. The mean
package year in the present smokers was 16.78 ± 16.31,
and the average smoking history was 30.39 ± 12.57 years.
In an age-adjusted correlation, we found a positive
correlation between the package years and the PAIx75
(r = 0.332, p = 0.015) and a negative correlation with the
ABI (r = −289; p = 0.036). The PWV and IMT showed no
significant correlations.
Table 2 shows the IMT, PWV, PAIx75 and ABI values
according to patient sex; the presence of diabetes, anti-
hypertensive, antidiabetic and lipid-lowering drugs. IMT
Table 1 Characteristics of patients by smoking status
Nonsmokers (n = 747) Former smokers (n = 469) Present smokers (n = 337) p value
Age (years)*¥ 56.14 (65.09-43.64) 55.69 (64.44-46.71) 48.24 (56.08-37.25) <0.001
Males (%) 212 (28.4) 271 (57.8) 133 (39.5) <0.001
Hypertension (%) 307 (41.1) 219 (46.7) 103 (30.6) <0.001
Diabetes (%) 79 (10.6) 65 (13.9) 34 (10.1) 0.145
Dyslipidemia (%) 214 (28.6) 177 (37.7) 82 (24.3) <0.001
Obesity (%) 161 (21.6) 114 (24.3) 62 (18.4) 0.124
Antihypertensive drugs (%) 223 (29.9) 162 (34.5) 66 (19.6) <0.001
Lipid-lowering drugs (%) 126 (16.9) 122 (26.0) 48 (14.2) <0.001
Antidiabetic drugs (%) 52 (7.0) 46 (9.8) 25 (7.4) 0.187
Office SBP (mmHg)*¥ 123.75 (134.63-113.50) 125.50 (138.00-114.50) 121.25 (131.38-109.13) <0.001
Office DBP (mmHg) 76.50 (83.50-70.50) 77.00 (83.38-70.00) 75.50 (82.50-70.00) 0.377
Office heart rate (bpm)*¥# 71.50 (78.50-64.50) 69.50 (76.50-61.13) 75.00 (82.63-67.00) <0.001
Central SBP (mmHg)*¥ 124 (135–114) 125 (137–115) 121 (132–110) 0.002
Central DBP (mmHg) 76 (83–70) 77 (84–70) 75 (82–68) 0.188
BMI (kg/m2)*¥ 26.67 (29.56-24.05) 27.07 (29.96-24.90) 25.64 (28.52-22.90) <0.001
Waist circumference (cm) ¥# 92 (100–84) 95 (104–88) 91.00 (99–82) <0.001
Total cholesterol (mg/dL) 215.41 ± 38.77 213.36 ± 39.10 210.74 ± 39.28 0.192
Triglycerides (mg/dL)* 95 (133–69) 96 (136–73) 104 (147–75) 0.026
LDL-cholesterol (mg/dL) 133.85 ± 36.78 133.18 ± 34.89 132.36 ± 36.75 0.827
HDL-cholesterol (mg/dL)*# 59.00 (70.00-49.00) 56.00 (67.00-47.00) 54.00 (64.75-45.00) <0.001
Mean IMT (mm) (n = 265) ¥ 0.68 ± 0.10 0.70 ± 0.11 0.65 ± 0.11 0.045
Maximum IMT (mm) (n = 265) ¥ 0.83 ± 0.12 0.86 ± 0.13 0.81 ± 0.13 0.042
PWV (m/sec) (n = 265) 7.10 (8.60-6.38) 7.30 (8.95-6.35) 6.65 (7.95-5.57) 0.032
PAIx75 (%) #¥ 89 (101–78) 86 (97–75) 90 (103–77) 0.003
ABI #¥ 1.17 ± 0.13 1.19 ± 0.14 1.16 ± 0.14 0.005
Normally distributed continuous variables are expressed as mean ± standard deviation, while non-normally distributed variables are presented as median and
75–25th percentile. Frequency distribution was used in categorical variables.
Obesity: BMI ≥ 30 Kg/m2or Waist circumference ≥ 88 cm in women and ≥ 102 cm in men. SBP: Systolic blood pressure; DBP: Diastolic blood pressure; BMI: body
mass index; HDL: high density lipoprotein; LDL: lowdensity lipoprotein; IMT: Intima Media Thickness; PWV: pulse wave velocity; PAIx75: Peripheral or radial
augmentation index adjusted for heart rate at 75 bpm, ABI: ankle brachial index.
*Differences between present and nonsmokers, ¥: Differences between present and former smokers, #: Differences between former and nonsmokers.
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and patients undergoing vascular treatment. The PAIx
75 shows the highest values in females, individuals with
diabetes and patients undergoing vascular treatments,
while the ABI shows differences in individuals with and
without diabetes.
Table 3 shows a bivariate correlation between systolic
blood pressure, heart rate and body mass index with each
vascular structure and functional parameter (i.e., PWV,
IMT, PAIx75 and ABI) analysed. Age shows a linear re-
lationship with PWV, IMT and PAIx75 (Figure 1).
After controlling for the effects of age, sex, systolic blood
pressure, heart rate, body mass index, HDL-cholesterol,
diabetes and the presence of antihypertensive, antidiabetic
and lipid-lowering drugs, the multivariate analysis showsthat present smokers have higher IMT values (p = 0.011).
PWV behaves likewise, although it does not reach the level
of statistical significance. ABI has no modifications, and
PAIx75 has higher values in current smokers than in
former smokers (Figure 2). More details of the multi-
variate analysis are shown in Table 2 of the Additional
file 2: (Table S2).
Discussion
In this paper, we present data about the relationship be-
tween smoking status and a large variety of parameters
that assess vascular structure and function in a general
population sample from primary care clinics. To assess
vascular structure and function, parameters differ in
their relationships with cardiovascular risk factors. The
Table 2 Values of vascular structure and functional parameters according to sex and presence of diabetes,
antihypertensive, antidiabetic and lipid lowering drugs
PWV (n = 265) IMT (n = 265) PAIx75 (n = 1553) ABI (n = 1553)
p-value p-value p-value p-value
Sex
Male 7.6 (6.7-9.5) <0.001 0.71 ± 0.12 <0.001 83 (94–71) <0.001 1.18 ± 0.14 0.455
Female 6.8 (6.0-7.9) 0.66 ± 0.09 91 (105–81) 1.17 ± 0.13
Diabetes
Yes 9.6 (8.3-10.9) <0.001 0.74 ± 0.07 0.007 93 (104–92) 0.001 1.15 ± 0.16 0.022
No 7.0 (6.1-8.2) 0.67 ± 0.11 87 (100–77) 1.18 ± 0.13
Antihypertensive drugs
Yes 8.3 (7.3-9.8) <0.001 0.74 ± 0.10 <0.001 89 (102–79) 0.033 1.18 ± 0.14 0.693
No 6.8 (5.9-7.8) 0.66 ± 0.10 87(100–76) 1.17 ± 0.13
Antidiabetic drugs
Yes 9.5 (10.6-8.5) <0.001 0.74 ± 0.08 0.048 93 (102–83) 0.004 1.14 ± 0.16 0.007
No 7.0 (8.2-6.2) 0.68 ± 0.10 88 (100–77) 1.18 ± 0.13
Lipid lowering drugs
Yes 8.1 (6.9-10.8) <0.001 0.74 ± 0.09 <0.001 91 (103–80) 0.004 1.17 ± 0.14 0.438
No 6.9 (6.1-8.2) 0.67 ± 0.10 87 (100–77) 1.17 ± 0.13
IMT: Intima Media Thickness; PWV: pulse wave velocity; PAIx75: Peripheral or radial augmentation index adjusted for heart rate at 75 bpm, ABI: ankle
brachial index.
PWV and PAIx75 are showed in median and interquartil range and IMT and ABI as mean ± Standard deviation.
p-values are for comparison of subgroups by T-Student independent groups and U Mann Whitney test.
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best relates to smoking status in a representative sample
of adult population. After controlling for the effects of
sex and other confounders, present smokers have higher
mean IMT values (p = 0.011), while the differences in PWV,
PAIx75 and ABI did not reach the level of statistical
significance.
The study results concerning the effects of smoking
status on subclinical arterial disease align with those of
other authors [1,2], indicating that smoking relates to
the presence of subclinical atherosclerosis in an adultTable 3 Bivariate correlations between vascular structure
and functional parameters and systolic blood pressure,
heart ratio and body mass index
Age SBP HR BMI
PWV (n = 265) 0.558** 0.623** 0.169** 0.353**
IMT (n = 265) 0.687** 0.441** −0.054 0.250**
PAIx75 (n = 1553) 0.222** 0.134** 0.361** 0.103**
ABI (n = 1553) 0.045 −0.063* −0.038 0.033
*p < 0.05, **p < 0.01.
SBP: Systolic blood pressure; HR: heart rate; BMI: body mass index; IMT: Intima
Media Thickness; PWV: pulse wave velocity; PAIx75: Peripheral or radial
augmentation index adjusted for heart rate at 75 bpm, ABI: ankle
brachial index.population. Some authors have reported that smoking
aligned with increased inflammatory markers [19,20]. Other
authors have shown that the polymorphism -930A/G may
modify the association between smoking and IMT values,
particularly among healthy young adults [21]. We found
no correlation between the mean package years in present
smokers with IMT. This result can be explained by the
small number of present smokers for whom the IMT
was analysed.
After controlling for confounders, we found no asso-
ciation between the presence of smoking and increased
arterial stiffness. In a systematic literature review, Doonan
RJ et al. [22] found that some studies found no significant
difference in the arterial stiffness between non-smokers
and long-term smokers; they concluded that the effect
of smoking on arterial stiffness remains to be established
by prospective smoking cessation trials. Rhee et al. found
an association between PWV and cigarette smoking in male
smokers with hypertension. Their study explored the acute
effects of smoking in a sample of men with and without
hypertension, while our work examined the chronic effects
of smoking on a larger sample of the Spanish general
population. Other differences between the study of Rhee
and Kubozono [3,4] and our work are the different vari-
ables used in the multiple regression models. Age and
SBP [10] are among the major determinants of PWV.
Figure 1 Scatterplots representing the relationship between age and each vascular structure and functional parameter analysed
(PWV r = 0.558; p < 0.01, IMT r = 0.687; p < 0.01, PAIx75 r = 0.222; p < 0.01 and ABI r = 0.045; p > 0.05).
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had lower SBP values. Although these variables were
included in the multivariate analysis model, it may not
be sufficient to control the effects that they may have
on the study results.
Previous studies have demonstrated an association
between AIx and cardiovascular risk factors, including
smoking [6,23]. In our work, the highest BMI corre-
sponds to the former smokers group, which could ex-
plain the lower value of PAIx75 in this group because
the augmentation index decreases when BMI increases
[24]. Among the major determinants of PAIx75 are the
patient age, SBP and BMI. In our study, the smoking
group had the youngest participants and lower SBP
and BMI levels. Although these two variables were in-
cluded in the multivariate analysis, they may not suffi-
ciently counteract the effects of other variables in the
study. Furthermore, Janner JH et al. and Minami J et al.
[6,23] analysed the relationship of smoking with CAIx,while in our work we use the radial or peripheral aug-
mentation index. Radial and central AIx are not inter-
changeable in the clinical practice, although the radial
augmentation index has been established as a marker
of vascular aging [25].
Present smokers have lower ABI values, similar to the
results of other authors [7,26]. However, our results did
not remain significant after adjusting for confounders.
The study population of Lee YH et al. [26] was from the
general population with a mean age of 65 and 70 years
in subjects with and without peripheral arterial disease,
respectively. The peripheral arterial disease is one of
the major manifestations of generalised atherosclerotic
disease, as a result of progressive atherosclerosis [27];
therefore, it is expected that individuals with longer
smoking histories will have lower ABI values. The
population studied in our work has a lower median age
(52.9 ± 13 years), with the youngest members in the
smoking group.
Figure 2 Relationship between the smoking status, vascular structure and function parameters adjusted by age, sex, systolic blood pressure,
heart rate, body mass index, HDL cholesterol, diabetes and the presence of antihypertensive, antidiabetic and lipid-lowering drugs.
Figure represents the adjusted means and 95% CI. Statistical significance: IMT p = 0.011*, PWV p = 0.872, PAIx75 p = 0.150, ABI p = 0.464.
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http://www.biomedcentral.com/1471-2261/13/109The main limitation of this study is the cross-sectional
design that prevents the establishment of causal rela-
tionships between smoking and vascular structure and
function. The participants of the three smoking categor-
ies differed in terms of age and the prevalence of other
risk factors. This limitation is, to some extent, addressed
by the statistical analysis that controls the effect of
these variables in the interpretation of results. Another
limitation of this study is that the smoking status was
self-reported and not determined by objective measures,
such as CO in the expired air analysis; however, such
questionnaires have been used previously in other studies
to explore the relationship between arterial stiffness and
smoking [5]. Lastly, a full set of data (IMT and PWV)
are only available in a small subset of the EVIDENT
study. However, this sample has similar demographic
and biological characteristics, according to smoking
status, compared to the overall sample analysed.Conclusions
Among the parameters vascular structure and function
analysed, only the IMT shows association with the smoking
status, after adjusting for confounders. Further studies
focusing on the smoking statuses of participants are
necessary to clarify the role of the chronic effects of
smoking on the parameters of vascular structure and
function and the effects of passive smoking exposure.Additional files
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Additional file 2: Table S2. Multivariate analysis of structure and
function vascular parameters with smoking status (GLM).Abbreviations
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